4-甲氧基-3-硝基苯甲腈 | 33224-23-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲氧基-3-硝基苯甲腈
• 英文名称: 4-Cyano-2-nitroanisol
• 英文别名: 4-methoxy-3-nitro-benzonitrile；4-methoxy-3-nitrobenzonitrile；5-Cyano-2-methoxynitrobenzene；3-Nitro-4-methoxy-benzoesaeure-nitril；3-Nitro-anissaeure-nitril；2-Nitro-4-cyanoanisol
• CAS: 33224-23-6
• 化学式: C₈H₆N₂O₃
• mdl: MFCD00221439
• 分子量: 178.147
• InChiKey: ACAYRJJVKPMSIS-UHFFFAOYSA-N

物化性质

• 熔点：
  148-150°C
• 沸点：
  330.2±27.0 °C(Predicted)
• 密度：
  1.32±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  78.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38
• 海关编码：
  2926909090
• 危险品运输编号：
  UN 3276
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P261,P280,P305+P351+P338,P311
• 危险性描述：
  H302+H312,H315,H319,H331,H335
• 储存条件：
  室温

SDS

Name:	4-Methoxy-3-nitrobenzonitrile 97% Material Safety Data Sheet
Synonym:
CAS:	33224-23-6

Section 1 - Chemical Product MSDS Name:4-Methoxy-3-nitrobenzonitrile 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
33224-23-6	4-Methoxy-3-nitrobenzonitrile		unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 33224-23-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 148 - 150 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6N2O3
Molecular Weight: 178

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Acids, bases, oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 33224-23-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Methoxy-3-nitrobenzonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 33224-23-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 33224-23-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 33224-23-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-甲氧基-3-硝基苯甲腈 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 以98%的产率得到5-氰基-2-甲氧基-苯胺
  参考文献：
  名称：

  阳离子1,4-二苯基-1H-1,2,3-三唑的合成及抗原虫活性

  摘要：

  新型双阳离子三唑1 - 60由相应的二腈通过 Pinner 方法合成，通过铜（I）催化的叠氮化物-炔环加成（CuAAC）制备。的类型和阳离子部分的放置以及在化合物的体外抗原生动物活性影响芳族取代基的性质1 - 60对布氏锥虫罗得西亚，恶性疟原虫，和杜氏利什曼原虫和它们的用于哺乳动物细胞的细胞毒性。八个同源物显示出低于 10 nM 的抗锥虫 IC 50值。39 种药物对恶性疟原虫更有效比喷他脒 (IC 50 = 58 nM)，并且八种类似物的活性高于青蒿素 (IC 50 = 6 nM)。二咪唑啉60表现出0.6 nM 的抗疟原虫IC 50值。在非洲锥虫病急性小鼠模型中，通过腹膜内途径以 4 × 5 mg/kg 给药的七种同源物至少治愈了四只动物中的三只。在 4 × 1 mg/kg 时，二脒46显示出比美拉索罗更好的抗锥虫效果，治愈所有感染的小鼠。

  DOI：

  10.1021/jm901178d
• 作为产物：
  描述：

  4-甲氧基苯甲腈 在 三氟甲磺酸酐 、 乙胺硝酸盐 作用下， 反应 0.25h， 以98%的产率得到4-甲氧基-3-硝基苯甲腈
  参考文献：
  名称：

  硝酸乙铵（EAN）/ Tf 2 O和EAN / TFAA：基于离子液体的芳族硝化系统

  摘要：

  EAN / Tf 2 O和EAN / TFAA系统充当原位硝酸三氟硝酸盐（TfONO 2）和三氟乙酰硝酸盐（CF 3 COONO 2）的来源，通过易位易位的硝酸乙基铵（EAN）离子液体作为溶剂进行复分解生成。是强大的亲电硝化试剂，适用于各种芳香族和杂芳香族化合物。对比硝化实验表明，对于高度失活的系统，硝化EAN / Tf 2 O优于EAN / TFAA。在报道的共价硝酸盐和预先形成的硝鎓盐的值之间，两种系统均显示出较低的底物选择性（K T / K B = 5-10）。

  DOI：

  10.1021/jo201374a

文献信息

• Benzopyran derivatives
  申请人：Recordati, S.A. Chemical and Pharmaceutical Company

  公开号：US06403594B1

  公开（公告）日：2002-06-11

  The invention relates to novel benzopyran derivatives of formula I, their N-oxides and pharmaceutically acceptable salts thereof. The compounds are endowed with enhanced selectivity for alpha1-adrenergic receptors and a low activity in lowering blood pressure. The compounds are useful in the treatment of obstructive syndromes of the lower urinary tract, including benign prostatic hyperplasia (BPH), and in the treatment of lower urinary tract symptoms (LUTS), neurogenic lower urinary tract dysfunction (NLUTD), and other conditions.

  该发明涉及公式I的新型苯并吡喃衍生物，它们的N-氧化物及其药用可接受的盐。这些化合物具有增强的α1-肾上腺素受体选择性和降低血压活性较低。这些化合物在治疗下尿路梗阻综合症，包括良性前列腺增生（BPH），以及治疗下尿路症状（LUTS），神经源性下尿路功能障碍（NLUTD）和其他疾病方面是有用的。
• BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION
  申请人：JACKSON Paul Francis

  公开号：US20120129842A1

  公开（公告）日：2012-05-24

  This invention relates to bisthiazole I and its therapeutic and prophylactic uses, wherein the variables A, R 5 , R 6 , and R 7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

  本发明涉及双噻唑I及其治疗和预防用途，其中变量A，R 5 ，R 6 ，和R 7 在说明书中定义。治疗的和/或预防的疾病包括类风湿性关节炎。
• Benzothiazole derivatives with activity as adenosine receptor ligands
  申请人：——

  公开号：US20020045615A1

  公开（公告）日：2002-04-18

  The present invention relates to substituted benzothiazole derivitives and to their pharmaceutically acceptable salts useful for the treatment of diseases related to the adenosine receptor.

  本发明涉及替代苯并噻唑衍生物及其药用可接受的盐，用于治疗与腺苷受体相关的疾病。
• 6,5-Fused bicyclic heterocycles
  申请人：——

  公开号：US20040014759A1

  公开（公告）日：2004-01-22

  The present invention provides compounds of Formula (I) wherein Q 1 , Q 2 , Q 3 , Q 4 , Y 1 , Y 2 , and Z are as defined in the description, and pharmaceutically acceptable salts thereof, and C 1 -C 8 alkyl esters thereof, which are useful for the treatment of diseases responsive to the inhibition of the enzyme 15-lipoxygenase. Thus, the compounds of Formula (I) and their pharmaceuticalyl acceptable salts are useful for treating diseases with an inflammatory component, including atherosclerosis, diseases involving chemotaxis of monocytes, inflammation, stroke, coronary artery disease, asthma, arthritis, colorectal cancer, and psoriasis. 1

  本发明提供了Formula (I)中的化合物，其中Q1、Q2、Q3、Q4、Y1、Y2和Z如描述中定义，并且其药用盐和C1-C8烷基酯，这些化合物对于治疗对15-脂氧合酶抑制有响应的疾病是有用的。因此，Formula (I)中的化合物及其药用盐对于治疗具有炎症成分的疾病是有用的，包括动脉粥样硬化、涉及单核细胞趋化、炎症、中风、冠状动脉疾病、哮喘、关节炎、结直肠癌和银屑病。
• 13C NMR spectra of substitutedo-nitroanisoles andn-butylo-nitrophenyl ethers
  作者：Petrus J. Zeegers、Malcolm J. Thompson

  DOI：10.1002/mrc.1260300607

  日期：1992.6

  13C NMR analyses of substituted o-nitroanisoles and n-butyl o-nitrophenyl ethers are reported.

  报告了取代的o-硝基甲苯和n-丁基o-硝基苯醚的13C NMR分析。